The Filer, Aralez Pharmaceuticals Canada Inc., applied for an order to cease to be a reporting issuer in all jurisdictions of Canada where it is a reporting issuer.
The Filer became a wholly-owned subsidiary of Searchlight Pharma Inc. following a statutory plan of arrangement.
The Filer's common shares were delisted from the Toronto Stock Exchange, and it has no other outstanding securities.
The principal regulator granted the order, finding that the Filer met the requirements under the applicable securities legislation.